BREAUX CASTLEMAN - Corporate Board Profile

STRATA Skin Sciences, Inc.

Filing Date	Source Excerpt
2006-04-18	Breaux Castleman has served as a member of our board of directors and Chairman of our board since July 2003. Since August 2001, he has served as President, Chief Executive Officer and Chairman of Syntiro Healthcare Services, Inc. Mr. Castleman also serves as a director of FemPartners, Inc. and Integrated Diagnostic Centers, Inc., each of which is a privately-held company. From December 1999 to July 2001, he served as Chief Executive Officer of Physia Corp. He served as President of Scripps Clinic from July 1996 to November 1999. He holds a B.A. in economics from Yale University and attended New York University Graduate School of Business Administration.
2007-04-20	Breaux Castleman has served as a member of our Board of Directors and Chairman of our Board since July 2003. ... Mr. Castleman receives consulting fees and director compensation totaling $73,650 in 2006.
2008-04-15	Breaux Castleman has served as a member of our Board of Directors and Chairman of our Board of Directors since July 2003. The compensation table shows he earned $67,300 in 2007.
2009-04-17	Breaux Castleman has served as a member of our Board of Directors and Chairman of our Board of Directors since July 2003. Since August 2001, he has served as President, Chief Executive Officer and Chairman of Syntiro Healthcare Services, Inc. Mr. Castleman also serves as a director of FemPartners, Inc. which is a privately-held company. From December 1999 to July 2001, he served as Chief Executive Officer of Physia Corp. He served as President of Scripps Clinic from July 1996 to November 1998. He holds a B.A. in economics from Yale University and attended New York University Graduate School of Business Administration.
2010-03-25	Breaux Castleman has served as a member of our Board of Directors and as Chairman of our Board of Directors since July 2003 and has been a consultant to the Company since June 2003. For 2009 our non-employee directors received an annual fee of $10,000 for serving as directors and an additional $500 per meeting for each full board or committee meeting attended. The chairman of each of our compensation committee, our audit committee and our nominating committee received an additional annual fee of $10,000. Also in December 2009, each of our non-employee directors received an annual stock option grant to purchase up to 7,500 shares of common stock. Such stock options will vest in full upon the first anniversary of issuance and have an exercise price equal to the closing price of our common stock on the date of the grant. Mr. Castleman’s 2009 consulting fees related to obtaining FDA approval of MelaFind, financial reporting and our business and financial strategy amounted to $24,000. Total compensation for Mr. Castleman was $91,875.
2011-03-24	Breaux Castleman has served as a member of our Board of Directors and as Chairman of our Board of Directors since July 2003 and has been a consultant to the Company since June 2003. For 2010 our non-employee directors received an annual fee of $15,000 for serving as directors and an additional $500 per meeting for each full board or committee meeting attended. In addition, the chairman of each of our compensation committee, our audit committee and our nominating committee received an additional annual fee of $10,000. Also in December 2010, each of our non-employee directors received an annual stock option grant to purchase up to 7,500 shares of common stock in respect of their service as directors for that year. Such stock options will vest in full upon the first anniversary of issuance and have an exercise price equal to the closing price of our common stock on the date of the grant. Mr. Castleman’s 2010 consulting fees related to obtaining FDA approval of MelaFind, financial reporting and our business and financial strategy amounted to $24,000.